|
1.
|
SM BentzenHS PoulsenS KaaeOM JensenH
JohansenHT MouridsenPrognostic factors in osteosarcomas. A
regression
analysisCancer62194202198810.1002/1097-0142(19880701)62:1%3C194::AID-CNCR2820620129%3E3.0.CO;2-83164231
|
|
2.
|
AM DavisRS BellPJ GoodwinPrognostic
factors in osteosarcoma: a critical reviewJ Clin
Oncol1242343119948113851
|
|
3.
|
HJ MankinFJ HornicekAE RosenbergDC
HarmonMC GebhardtSurvival data for 648 patients with osteosarcoma
treated at one institutionClin Orthop Relat
Res429286291200410.1097/01.blo.0000145991.65770.e615577500
|
|
4.
|
V AmbrosRC LeeIdentification of microRNAs
and other tiny noncoding RNAs by cDNA cloningMethods Mol
Biol265131158200415103073
|
|
5.
|
RS PillaiSN BhattacharyyaW
FilipowiczRepression of protein synthesis by miRNAs: how many
mechanisms?Trends Cell
Biol17118126200710.1016/j.tcb.2006.12.00717197185
|
|
6.
|
DP BartelMicroRNAs: genomics, biogenesis,
mechanism and
functionCell116281297200410.1016/S0092-8674(04)00045-514744438
|
|
7.
|
C CaldasJD BrentonSizing up miRNAs as
cancer genesNat Med11712714200510.1038/nm0705-71216015356
|
|
8.
|
GA CalinCM CroceMicroRNA signatures in
human cancersNat Rev Cancer6857866200610.1038/nrc199717060945
|
|
9.
|
B KefasJ GodlewskiL ComeauY LiR AbounaderM
HawkinsonmicroRNA-7 inhibits the epidermal growth factor receptor
and the Akt pathway and is downregulated in glioblastomaCancer
Res6835663572200810.1158/0008-5472.CAN-07-663918483236
|
|
10.
|
Y LadeiroG CouchyC BalabaudP Bioulac-SageL
PelletierJ Zucman-RossiMicroRNA profiling in hepatocellular tumors
is associated with clinical features and oncogene/tumor suppressor
gene mutationsHepatology4719551963200810.1002/hep.2225618433021
|
|
11.
|
K MotoyamaH InoueY TakatsunoOver- and
under-expressed microRNAs in human colorectal cancerInt J
Oncol3410691075200919287964
|
|
12.
|
X AgirreA Jimenez-VelascoE San
Jose-EnerizL GarateE BandresDown-regulation of hsa-miR-10a in
chronic myeloid leukemia CD34+ cells increases
USF2-mediated cell growthMol Cancer
Res618301840200810.1158/1541-7786.MCR-08-016719074828
|
|
13.
|
MD MattieCC BenzJ BowersK
SensingerOptimized high-throughput microRNA expression profiling
provides novel biomarker assessment of clinical prostate and breast
cancer biopsiesMol Cancer524200610.1186/1476-4598-5-24
|
|
14.
|
G WangW MaoS ZhengMicroRNA-183 regulates
Ezrin expression in lung cancer cellsFEBS
Lett58236633668200810.1016/j.febslet.2008.09.05118840437
|
|
15.
|
X ChenTT YangW WangHH SunEstablishment and
characterization of human osteosarcoma cell lines with different
pulmonary metastatic
potentialsCytotechnology613744200910.1007/s10616-009-9239-320016965
|
|
16.
|
E BandresE CubedoX AgirreR MalumbresR
ZarateIdentification by real-time PCR of 13 mature microRNAs
differentially expressed in colorectal cancer and non-tumoral
tissuesMol Cancer529200610.1186/1476-4598-5-2916854228
|
|
17.
|
AJ LoweryN MillerRM DwyerMJ
KerinDysregulated miR-183 inhibits migration in breast cancer
cellsBMC Cancer10502201010.1186/1471-2407-10-50220858276
|
|
18.
|
JG DoenchPA SharpSpecificity of microRNA
target selection in translational repressionGenes
Dev18504511200410.1101/gad.118440415014042
|
|
19.
|
SF TavazoieC AlarconT OskarssonEndogenous
human microRNAs that suppress breast cancer
metastasisNature451147152200810.1038/nature0648718185580
|
|
20.
|
KR LeiteJM Sousa-CanavezST ReisAH
TomiyamaLH Camara-LopesA SañudoAA AntunesM SrouqiChange in
expression of miR-let7c, miR-100 and miR-218 from high grade
localized prostate cancer to metastasisUrol
Oncol29265269201110.1016/j.urolonc.2009.02.00219372056
|
|
21.
|
GK ScottA GogaD BhaumikCE BergerCS
SullivanCC BenzCoordinate suppression of ERBB2 and ERBB3 by
enforced expression of micro-RNA, miR-125a or miR-125bJ Biol
Chem28214791486200710.1074/jbc.M60938320017110380
|
|
22.
|
MS KumarJ LuKL MercerTR GolubT
JacksImpaired microRNA processing enhances cellular transformation
and tumorigenesisNat Genet39673677200710.1038/ng200317401365
|
|
23.
|
J MazarD DeBlasioSS GovindarajanS ZhangRJ
PereraEpigenetic regulation of microRNA-375 and its role in
melanoma development in humansFEBS
Lett58524672476201110.1016/j.febslet.2011.06.02521723283
|
|
24.
|
L WuC CaiX WangM LiuX LiH
TangMicroRNA-142-3p, a new regulator of RAC1, suppresses the
migration and invasion of hepatocellular carcinoma cellsFEBS
Lett58513221330201110.1016/j.febslet.2011.03.06721482222
|
|
25.
|
S TanR LiK DingPE LobieT ZhumiR-198
inhibits migration and invasion of hepatocellular carcinoma cells
by targeting the HGF/c-MET pathwayFEBS
Lett58522292234201110.1016/j.febslet.2011.05.04221658389
|
|
26.
|
G LiC LunaJ QiuDL EpsteinP
GonzalezTargeting of integrin beta1 and kinesin 2alpha by microRNA
183J Biol Chem28554615471201010.1074/jbc.M109.03712719940135
|
|
27.
|
A KrekD GrunMN PoyR WolfL RosenbergEJ
EpsteinP MacMenaminI da PiedadeKC GunsalusM StoffelN
RajewskyCombinatorial microRNA target predictionsNat
Genet37495500200510.1038/ng1536
|
|
28.
|
Y YuJ KhanC KhannaL HelmanPS MeltzerG
MerlinomExpression profiling identifies the cytoskeletal organizer
ezrin and the developmental homeoprotein Six21 as key metastatic
regulatorsNat Med10175181200410.1038/nm96614704789
|
|
29.
|
P MangeatC RoyM MartinERM proteins in cell
adhesion and membrane dynamicsTrends Cell
Biol9187192199910.1016/S0962-8924(99)01544-510322453
|
|
30.
|
A BretscherK EdwardsRG FehonERM proteins
and merlin: integrators at the cell cortexNat Rev Mol Cell
Biol3586599200210.1038/nrm88212154370
|
|
31.
|
JW WangSY PengJT LiY WangZP ZhangY ChengDQ
ChengWH WengXS WuXZ FeiIdentification of metastasis-associated
proteins involved in gallbladder carcinoma metastasis by proteomic
analysis and functional exploration of chloride intracellular
channel 1Cancer Lett2817181200910.1016/j.canlet.2009.02.020
|
|
32.
|
KW HunterEzrin, a key component in tumor
metastasisTrends Mol
Med10201204200410.1016/j.molmed.2004.03.00115121044
|
|
33.
|
WH WengJ AhlenK AstromWO LuiC
LarssonPrognostic impact of immunohistochemical expression of ezrin
in highly malignant soft tissue sarcomasClin Cancer
Res1161986204200510.1158/1078-0432.CCR-05-054816144921
|
|
34.
|
C KhannaX WanS BoseR CassadayO OlomuA
MendozaC YeungR GorlickSM HewittLJ HelmanThe membrane cytoskeleton
linker ezrin is necessary for osteosarcoma metastasisNat
Med10182186200410.1038/nm98214704791
|
|
35.
|
MS KimWS SongWH ChoSY LeeDG JeonEzrin
expression predicts survival in stage IIB osteosarcomasClin Orthop
Relat Res459229236200710.1097/BLO.0b013e3180413dbf17353802
|
|
36.
|
S Xu-DongS ZanZ Shui-ErT Li-NaY Wen-XiL
FengY YangExpression of ezrin correlates with lung metastasis in
Chinese patients with osteosarcomaClin Invest
Med32E180E188200919331807
|
|
37.
|
YF WangJN ShenExpression change of ezrin
as a prognostic factor in primary osteosarcomaMed
Oncol28S636S643201110.1007/s12032-010-9684-z20859706
|
|
38.
|
HW KangF WangmiR-20a promotes migration
and invasion by regulating TNKS2 in human cervical cancer cellsFEBS
Lett586897904201210.1016/j.febslet.2012.02.02022449978
|
|
39.
|
L WuH LiCY JiaW ChengMicroRNA-223
regulates FOXO1 expression and cell proliferationFEBS
Lett58610381043201210.1016/j.febslet.2012.02.05022569260
|
|
40.
|
N HuangJ LinJ RuanN SuMiR-219-5p inhibits
hepatocellular carcinoma cell proliferation by targeting
glypican-3FEBS
Lett586884891201210.1016/j.febslet.2012.02.01722449976
|
